One-fifth of CME clearing members hit by Ion hack

Advisory committee heard CFTC believed it could “play a more direct role” in cyber security practices

Around 20% of all CME Group clearing members were affected by the Ion ransomware event, an executive at the clearing house has told a public hearing.

Ion Group, which supplies software used to process cleared derivatives trades, had to shut down access to some of its services on January 31 after hackers seized control of its servers.

The outage affected 42 Ion clients, forcing some to process trades manually and delay regulatory reporting. CME has 67 clearing members.

Julie Holzrichter, CME

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

Three steps to build resilience to cyber attacks

As cyber criminals grow more sophisticated, and regulators bear down on banks and their third parties, there are three steps firms can take today to boost their resilience to cyber threats, says Jason Harrell of the DTCC

EU lawmakers struggle to find common ground on equities CT

The debate over a consolidated tape for European equities heated up when a second contender for the role of provider emerged during the EU’s trilogue process. But as the bloc’s three legislative bodies try to reach a compromise, commercial interests are proving inescapable.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here